Mancini Anthony
Reporting owner on Forms 3, 4 and 5, CIK 2124509.
Mancini Anthony reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-09-28.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Revolution Medicines, Inc. CIK 1628171 | officer (See Remarks) | 1 | 2026-09-28 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Revolution Medicines, Inc. Common Stock | 2026-09-25 | M exercised | +3,121 | $33.62 | 42,886 | Form 4 |
| Revolution Medicines, Inc. Common Stock | 2026-09-25 | S sold | -3,121 | $200.54 | 39,765 | Form 4 |
| Revolution Medicines, Inc. Stock Option (Right to Buy), derivative | 2026-09-25 | M exercised | -3,121 | $0 | 93,625 | Form 4 |
| Revolution Medicines, Inc. Common Stock | 2026-09-24 | S sold | -587 | $200 | 39,765 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0002124509-26-000012 | Revolution Medicines, Inc. | 2026-09-28 |